Investigation of Phytochemical Screening, <i>in vivo</i> Antidiabetic, and Neuroprotective Potential of <i>Stephania glabra</i> L. Tuber and <i>Clerodendrum phlomidis</i> L. Leaves

Diabetes, depression, and Alzheimer’s disease share an intricate relationship, wherein chronic metabolic dysregulation serves as a common underlying factor contributing to both neurodegenerative and metabolic dysregulation outcomes. The tuber of Stephania glabra L. and the leaves of Clerodendrum phlomidis L. are traditionally recognised for their rich phytochemical composition and are believed to possess antidiabetic, antidepressant, and anti-Alzheimer’s potential. Therefore, the present investigation focused on subacute toxicity studies (500–2000 mg/kg) confirm that the ethanolic tuber extracts of S. glabra L. and leaves of C. phlomidis L. are non-toxic and harmless at 100, 200, and 500 mg/kg, exhibiting notable antidiabetic activity, evidenced by improved glycemic control and enhanced restoration of endocrine pancreatic Islets. The plant extracts demonstrated anti-Alzheimer’s activity, as evidenced by Cognitive assessment tools, including the Morris Water Maze and Y-Maze. Antidepressant potential was confirmed by a significant reduction of Stagnation (Immobility Time) in the Tail Suspension and Porsolt Swim Test. The findings indicate that the extracts demonstrated notable antidiabetic, antidepressant, and anti-Alzheimer’s effects, with increasing efficacy observed at 100, 200, and 400 mg/kg. Treatment improved glycemic control, cognitive performance, and reduced depressive-like behaviours. These findings highlight their therapeutic promise in metabolic and neurodegenerative disorders. Major Findings: Ethanolic extracts of S. glabra tuber and C. phlomidis leaves were phytochemically rich. The extracts significantly reduced blood glucose levels and improved cognitive behaviors, indicating therapeutic potential against neuroendocrinal disorders.

View article page

Download PDF